The Food and Drug Administration (FDA) has granted Priority Review to the Biologics License Application (BLA) for deramiocel (CAP-1002) for the treatment ...

The Food and Drug Administration (FDA) has approved Stoboclo® (denosumab-bmwo), a biosimilar to Prolia® (denosumab), and Osenvelt® (denosumab-bmwo), a ...

The Food and Drug Administration (FDA) has approved Purified Cortrophin ® Gel (repository corticotropin injection USP) in a prefilled syringe presentation. Cortrophin Gel is a purified ...

In honor of Women’s History Month, MPR has created a quiz to celebrate the groundbreaking contributions of women in medicine. Test your knowledge and see ...

Significant reduction seen in median headache days per month in both intractable and nonintractable migraine groups ...

After adjustment for confounding variables, no increased risk seen for GLP-1 receptor agonists versus DPP-4 inhibitors, SGLT-2 inhibitors ...

Newly appointed health secretary believes processing the comments under the Richardson Waiver puts too heavy a burden on the department ...

Based on preliminary data for 2024 to 2025, 13% of pediatric deaths had influenza-associated encephalopathy, encephalitis.

The approval was supported by data from the registry-linked, parallel group, open-label, randomized AcT trial, which compared tenecteplase to alteplase.

The Food and Drug Administration (FDA) has granted Fast Track designation to LTG-001 for the treatment of acute pain. LTG-001, an oral Nav1.8 selective ...

Topline data were announced from a phase 3 trial evaluating rusfertide in patients with polycythemia vera (PV). The 3-part, randomized, ...

Galzin ® (zinc acetate capsules) is now available for maintenance treatment of patients with Wilson disease who have been initially treated with a chelating agent, according to Eton Pharmaceuticals.